전남대학교 중앙도서관

Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy.

학술저널

issue: Nature communications [Nat Commun] 2023 Feb 02; Vol. 14 (1), pp. 86. Date of Electronic Publication: 2023 Feb 02.
Author: Trefny MP; Laboratory of Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland. marcel.trefny@unibas.ch.
Kirchhammer N; Laboratory of Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.
Auf der Maur P; Laboratory of Tumor Heterogeneity, Metastasis and Resistance, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.
Natoli M; Laboratory of Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.
Schmid D; Laboratory of Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.
Germann M; Laboratory of Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.
Fernandez Rodriguez L; Laboratory of Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.
Herzig P; Laboratory of Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.
Lötscher J; Laboratory of Immunobiology, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.
Akrami M; Laboratory of Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.
Stinchcombe JC; Cambridge Institute for Medical Research, Biomedical Campus, Cambridge, CB2 0XY, UK.
Stanczak MA; Laboratory of Cancer Immunotherapy, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.
Zingg A; Laboratory of Cancer Immunotherapy, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.
Buchi M; Laboratory of Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.
Roux J; Bioinformatics Core Facility, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.; Swiss Institute of Bioinformatics, Basel, Switzerland.
Marone R; Laboratory of Molecular Immune Regulation, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.; Transplantation Immunology & Nephrology, Basel University Hospital, Basel, Switzerland.
Don L; Laboratory of Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.
Lardinois D; Department of Surgery, University Hospital Basel, Basel, Switzerland.
Wiese M; Department of Surgery, University Hospital Basel, Basel, Switzerland.
Jeker LT; Laboratory of Molecular Immune Regulation, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.; Transplantation Immunology & Nephrology, Basel University Hospital, Basel, Switzerland.
Bentires-Alj M; Laboratory of Tumor Heterogeneity, Metastasis and Resistance, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.
Rossy J; Biotechnology Institute Thurgau, University of Konstanz, Kreuzlingen, Switzerland.
Thommen DS; Laboratory of Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.; Division of Molecular Oncology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Griffiths GM; Cambridge Institute for Medical Research, Biomedical Campus, Cambridge, CB2 0XY, UK.
Läubli H; Laboratory of Cancer Immunotherapy, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.; Medical Oncology, University Hospital Basel, Basel, Switzerland.
Hess C; Laboratory of Immunobiology, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland.; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, University of Cambridge, Cambridge, CB2 0AW, UK.
Zippelius A; Laboratory of Cancer Immunology, Department of Biomedicine, University of Basel and University Hospital of Basel, Basel, Switzerland. alfred.zippelius@usb.ch.; Medical Oncology, University Hospital Basel, Basel, Switzerland. alfred.zippelius@usb.ch.
DB Label: Database : MEDLINE

원문보기: OA (Springer) Open Access (PubMed Central) OA (Nature) 등재 - Web of Science (SCIE) 등재 - SCOPUS 조회 - Impact Factor (JCR)

링크메뉴

주메뉴

전자자료 상세검색

전자자료 상세검색

전체선택